quantified levels of two metalloproteinases (MMP-2 and MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL) in urine samples collected from women with ovarian cancer and healthy controls. The gene discussed is MMP2; the disease is ovarian cancer.